ResMed Announces Participation in the 2023 KeyBanc Life Sciences & MedTech Investor Forum
ResMed (NYSE: RMD) announced that Rob Douglas, president and COO, will participate in a fireside chat at the 2023 KeyBanc Life Sciences & MedTech Investor Forum on March 21, 2023, at approximately 3:45 p.m. EDT. The event will be accessible via webcast. Interested parties can find more information and access the live audio-only webcast by visiting ResMed Investor Relations. A replay will be available 24 hours after the event and will remain accessible for 90 days. ResMed focuses on innovative digital health technologies and cloud-connected medical devices for chronic diseases.
- Rob Douglas's participation in a key investor forum enhances visibility and engagement with the investment community.
- ResMed's continued focus on innovative solutions positions the company strongly in the healthcare technology sector.
- None.
SAN DIEGO, March 15, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will join a fireside chat at the 2023 KeyBanc Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023, beginning at approximately 3:45 p.m. (Eastern Daylight Time) via webcast.
More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resmed.com. The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following ninety (90) days.
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
| For investors | For media |
| Amy Wakeham | Jayme Rubenstein |
| +1 858.836.5000 | +1 858.836.6798 |
| investorrelations@resmed.com | news@resmed.com |
FAQ
What event will ResMed's Rob Douglas attend on March 21, 2023?
How can I access the webcast for ResMed's investor forum participation?
What is the significance of Rob Douglas's participation in the investor forum for RMD stock?
